Mineralys Therapeutics (MLYS) Stock Chart & Stock Price History → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free MLYS Stock Alerts $12.77 +0.35 (+2.82%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Mineralys Therapeutics Stock Price Performance5 Day Performance+5.02%1 Month Performance-2.44%3 Month Performance-16.75%6 Month Performance+77.36%Year-To-Date Performance+48.49%1 Year Performance-13.25% Receive MLYS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBiotech's Best Kept Secret: Potential 46,751% GainThe world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>> MLYS Stock Chart for Sunday, June, 2, 2024 MLYS Chart by TradingView Mineralys Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$12.42$12.77+2.82%$12.81$12.35207,540 shs$634.03 million05/30/2024$12.31$12.42+0.89%$12.53$12.1695,356 shs$616.65 million05/29/2024$12.16$12.31+1.23%$12.38$11.8961,077 shs$611.18 million05/28/2024$12.20$12.16-0.33%$12.40$11.9382,488 shs$603.74 million05/27/2024$12.20$12.20$12.23$12.0044,900 shs$605.73 million05/24/2024$12.23$12.20-0.25%$12.23$12.0044,910 shs$605.72 million Get the Latest News and Ratings for MLYS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$12.52$12.23-2.32%$12.55$11.6969,348 shs$607.22 million05/22/2024$12.91$12.52-3.02%$13.10$12.5244,436 shs$621.62 million05/21/2024$12.81$12.91+0.78%$12.94$12.6163,666 shs$640.98 million05/20/2024$13.00$12.81-1.46%$13.05$12.8042,868 shs$636.02 million05/17/2024$13.15$13.00-1.14%$13.19$12.8345,212 shs$645.45 million05/16/2024$13.07$13.15+0.61%$13.27$12.9857,845 shs$652.90 million05/15/2024$13.06$13.07+0.08%$13.75$12.8875,448 shs$648.93 million05/14/2024$12.93$13.06+1.01%$13.23$12.6674,405 shs$648.42 million05/13/2024$13.52$12.93-4.36%$13.83$12.60127,536 shs$641.97 million05/10/2024$14.27$13.52-5.26%$14.21$13.12121,642 shs$671.01 million05/09/2024$14.65$14.27-2.59%$15.00$13.76189,561 shs$708.23 million05/08/2024$14.17$14.65+3.39%$14.87$13.78277,795 shs$727.08 million05/07/2024$13.75$14.17+3.05%$14.31$13.61382,280 shs$703.26 million05/06/2024$12.95$13.75+6.18%$13.97$12.99524,509 shs$682.41 million05/03/2024$13.09$12.95-1.07%$13.59$12.8171,802 shs$642.71 million05/02/2024$12.80$13.09+2.27%$13.23$12.73113,802 shs$649.66 million05/01/2024$12.25$12.80+4.49%$13.53$12.41369,927 shs$635.26 million04/30/2024$12.37$12.25-0.97%$12.46$11.95182,965 shs$607.97 million04/29/2024$11.87$12.37+4.21%$12.40$11.9349,614 shs$613.94 million04/26/2024$11.04$11.87+7.52%$11.90$11.1765,808 shs$589.11 million04/25/2024$11.36$11.04-2.82%$11.15$10.7052,708 shs$547.93 million04/24/2024$11.43$11.36-0.61%$11.67$11.2953,170 shs$563.80 million04/23/2024$11.14$11.43+2.60%$11.74$11.16139,595 shs$567.27 million04/22/2024$11.29$11.14-1.33%$11.42$10.9635,856 shs$552.88 million04/19/2024$10.75$11.29+5.02%$11.29$10.57102,466 shs$560.32 million04/18/2024$12.00$10.75-10.42%$12.02$10.37418,546 shs$533.52 million04/17/2024$12.07$12.00-0.58%$12.24$11.8986,933 shs$595.56 million04/16/2024$12.34$12.07-2.19%$12.50$12.0560,222 shs$599.03 million04/15/2024$13.01$12.34-5.15%$12.97$12.3246,275 shs$645.70 million04/12/2024$13.11$13.01-0.76%$13.41$12.7164,467 shs$645.69 million04/11/2024$12.84$13.11+2.10%$13.12$12.7770,505 shs$650.66 million04/10/2024$13.14$12.84-2.28%$13.14$12.6690,014 shs$637.25 million04/09/2024$13.26$13.14-0.90%$13.50$12.96151,946 shs$652.14 million04/08/2024$12.99$13.26+2.08%$13.75$13.09140,739 shs$658.09 millionThis military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.04/05/2024$12.61$12.99+3.01%$13.56$12.85224,030 shs$644.69 million04/04/2024$12.90$12.61-2.25%$13.04$12.5766,739 shs$625.83 million04/03/2024$12.58$12.90+2.54%$12.98$12.5053,721 shs$640.23 million04/02/2024$13.03$12.58-3.45%$12.92$12.50112,122 shs$624.35 million04/01/2024$12.91$13.03+0.93%$13.38$12.8086,136 shs$646.69 million03/29/2024$12.91$12.91$13.14$12.7466,761 shs$640.72 million03/28/2024$12.78$12.91+1.02%$13.14$12.7466,761 shs$640.72 million03/27/2024$12.84$12.78-0.47%$13.53$12.6975,310 shs$634.27 million03/26/2024$12.92$12.84-0.62%$13.06$12.6477,034 shs$637.26 million03/25/2024$12.84$12.92+0.62%$13.24$12.8070,351 shs$641.22 million03/22/2024$13.09$12.84-1.91%$13.12$12.63165,110 shs$527.72 million03/21/2024$13.39$13.09-2.24%$13.73$12.65422,264 shs$538.06 million03/20/2024$13.48$13.39-0.67%$13.86$12.87118,838 shs$550.33 million03/19/2024$12.61$13.48+6.90%$14.03$12.61187,502 shs$554.03 million03/18/2024$12.69$12.61-0.63%$12.89$12.4283,442 shs$518.27 million03/15/2024$12.60$12.69+0.71%$12.88$12.47211,732 shs$521.56 million03/14/2024$12.59$12.60+0.08%$12.77$12.3878,888 shs$517.86 million03/13/2024$12.86$12.59-2.10%$13.05$12.30376,021 shs$517.45 million03/12/2024$13.26$12.86-3.02%$13.30$12.6998,385 shs$528.61 million03/11/2024$14.10$13.26-5.96%$14.35$13.2283,192 shs$544.99 million03/08/2024$13.98$14.10+0.86%$14.55$13.53216,754 shs$579.51 million03/07/2024$14.00$13.98-0.14%$14.21$13.7674,818 shs$574.65 million03/06/2024$14.60$14.00-4.11%$14.88$13.83233,181 shs$575.40 million03/05/2024$14.99$14.60-2.60%$15.08$14.5878,462 shs$600.06 million03/04/2024$15.34$14.99-2.28%$15.45$14.70138,235 shs$616.09 million03/01/2024$15.38$15.34-0.26%$15.89$15.14207,232 shs$630.47 million Related Companies: CALT Stock Chart GHRS Stock Chart ZYME Stock Chart PHAT Stock Chart ANAB Stock Chart PHVS Stock Chart LYEL Stock Chart AVBP Stock Chart PHAR Stock Chart ABUS Stock Chart Receive MLYS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MLYS) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mineralys Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.